世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

再生医療用途のコラーゲンとゼラチン市場:原材料毎(牛、豚、魚介)、用途毎(創傷ケア、整形外科、心血管)、金額と数量の分析 - 2022年までの世界市場予測

Collagen & Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis - Global Forecast to 2022

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2017年8月US$4,950
シングルユーザライセンス
179 203

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の再生医療用途のコラーゲンとゼラチン市場に関する調査レポートです。

“Global collagen & gelatin market for regenerative medicine projected to grow at a CAGR of 10.1% and 7.8% respectively.”

The global collagen market for regenerative medicine is projected to grow from USD 420.6 million in 2017 to USD 679.9 million by 2022, at a CAGR of 10.1% during the forecast period. The global gelatin market for regenerative medicine is projected to grow from USD 65.2 million in 2017 to USD 94.9 million by 2022, at a CAGR of 7.8% during the forecast period. The key factors propelling the growth of the global collagen and gelatin market for regenerative medicine include rising prevalence of chronic diseases, rapid growth in aging population, and growing government & private funding to support the development of regenerative medicine. However, the availability of alternative biomaterials for regenerative medicine is expected to restrain the growth of this market.

“The marine collagen segment is expected to grow at the highest CAGR in the global collagen market for regenerative medicine.”

On the basis of source, the global collagen market for regenerative medicine has been classified into bovine collagen, porcine collagen, marine collagen, and other sources. In 2017, the bovine collagen segment is expected to command the largest share of the global collagen market for regenerative medicine. However, owing to advantages, such as low immunogenicity and high biocompatibility the marine collagen segment is projected to grow at the highest CAGR during the forecast period.

“The orthopedic segment is expected to grow at the highest CAGR in the global collagen market for regenerative medicine.”

On the basis of application, the global collagen market for regenerative medicine has been segmented into orthopedic, wound care, cardiovascular, and other applications. In 2017, the orthopedic applications segment is expected to command the largest share of the global collagen market for regenerative medicine. However, owing to factors such as rising prevalence of chronic wounds, the wound care segment is projected to register the highest CAGR during the forecast period.

“Asia-Pacific to witness the highest growth during the forecast period.”

North America held the largest share of the collagen market for regenerative medicine and gelatin market for regenerative medicine, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022 in both the markets. The high growth in the collagen market for regenerative medicine can primarily be attributed to the large number of CVD patients and diabetics with DFU (diabetic foot ulcers) in the region, increasing number of research studies, and increasing focus of industry players on emerging APAC countries. Similarly, the large number of patients suffering from skin burns & brain tumors and increasing number of research studies in the region are the major factors driving the growth of the APAC market.

Break of primary participants was as mentioned below:

• By Company Type – Tier 1–45%, Tier 2–40% and Tier 3–15%
• By Designation – C-level–41%, Director Level–30%, Others–29%
• By Region – North America–38%, Europe–31%, Asia-Pacific–19%, RoW–12%

The major players operating in the global collagen market for regenerative medicine include Integra LifeSciences Holding Corporation (U.S.), Collagen Matrix, Inc. (U.S.), Collagen Solutions plc (U.K.), Royal DSM (Netherlands), Vornia Biomaterials, Ltd. (Ireland), SYMATESE (France), and NuCollagen, LLC. (U.S.). Similarly, the major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium).

Research Coverage:

The report analyzes the global collagen and gelatin market for regenerative medicine and aims at estimating market size and future growth potential of this market based on various segments such as source, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned four strategies.

This report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global collagen and gelatin market for regenerative medicine. The report analyzes the global collagen and gelatin market for regenerative medicine by source, application, and region
• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for collagens and gelatins for regenerative medicine across various regions
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global collagen and gelatin market for regenerative medicine
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global collagen and gelatin market for regenerative medicine



目次

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1.1 RESEARCH METHODOLOGY STEPS 19
2.1.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.1.2.1 Secondary research 20
2.1.3 KEY DATA FROM SECONDARY SOURCES 20
2.1.3.1 Primary research 21
2.1.4 MARKET SIZE ESTIMATION METHODOLOGY 24
2.1.5 MARKET FORECAST METHODOLOGY 27
2.1.6 MARKET DATA VALIDATION AND TRIANGULATION 28
2.1.7 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 COLLAGEN MARKET FOR REGENERATIVE MEDICINE: MARKET OVERVIEW 35
4.2 GELATIN MARKET FOR REGENERATIVE MEDICINE: MARKET OVERVIEW 36
4.3 GLOBAL COLLAGEN MARKET SIZE FOR REGENERATIVE MEDICINE, BY SOURCE,
2017 VS. 2022 36
4.4 GLOBAL GELATIN MARKET SIZE FOR REGENERATIVE MEDICINE, BY APPLICATION,
2017 VS. 2022 37
4.5 GEOGRAPHIC SNAPSHOT OF GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE 37
4.6 GEOGRAPHIC SNAPSHOT OF GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Availability of government and private funding for R&D 41
5.2.1.2 Rising prevalence of chronic diseases 41
5.2.1.3 Rapid growth in aging population 41
5.2.2 RESTRAINTS 42
5.2.2.1 Availability of alternate biomaterials 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Increasing research on collagen and gelatin-based products 43
6 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE 44
6.1 INTRODUCTION 45
6.2 BOVINE COLLAGEN 46
6.3 PORCINE COLLAGEN 47
6.4 MARINE COLLAGEN 48
6.5 OTHER SOURCES 50
7 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE 51
7.1 INTRODUCTION 52
7.2 BOVINE GELATIN 53
7.3 PORCINE GELATIN 54
7.4 OTHER SOURCES 55
8 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 57
8.1 INTRODUCTION 58
8.2 ORTHOPEDIC APPLICATIONS 59
8.3 WOUND CARE 61
8.4 CARDIOVASCULAR APPLICATIONS 62
8.5 OTHER APPLICATIONS 63
9 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 65
9.1 INTRODUCTION 66
9.2 WOUND CARE 67
9.3 ORTHOPEDIC APPLICATIONS 68
9.4 CARDIOVASCULAR AND THORACIC APPLICATIONS 69
9.5 OTHER APPLICATIONS 71
10 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION 72
10.1 INTRODUCTION 73
10.2 NORTH AMERICA 75
10.2.1 U.S. 78
10.2.2 CANADA 81
10.3 EUROPE 84
10.3.1 EUROPE-5 87
10.3.2 REST OF EUROPE (ROE) 90

10.4 ASIA-PACIFIC 93
10.4.1 JAPAN 98
10.4.2 INDIA 100
10.4.3 CHINA 102
10.4.4 ROAPAC 104
10.5 REST OF THE WORLD (ROW) 106
11 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION 109
11.1 INTRODUCTION 110
11.2 NORTH AMERICA 112
11.2.1 U.S. 115
11.2.2 CANADA 118
11.3 EUROPE 121
11.3.1 EUROPE-5 124
11.3.2 REST OF EUROPE (ROE) 126
11.4 ASIA-PACIFIC 129
11.4.1 JAPAN 133
11.4.2 INDIA 135
11.4.3 CHINA 137
11.4.4 ROAPAC 139
11.5 REST OF THE WORLD (ROW) 141
12 COMPETITIVE LANDSCAPE 145
12.1 OVERVIEW 145
12.2 COMPETITIVE SITUATION AND TRENDS 146
12.3 AGREEMENTS, COLLABORATIONS, AND CONTRACTS 147
12.4 ACQUISITIONS 148
12.5 APPROVALS 149
12.6 OTHER STRATEGIES 150

13 COMPANY PROFILE 152
(OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS.)*
13.1 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 152
13.2 COLLAGEN MATRIX, INC. 155
13.3 COLLAGEN SOLUTIONS PLC 157
13.4 ROYAL DSM 160
13.5 VORNIA BIOMATERIALS, LTD. 162
13.6 SYMATESE 163
13.7 NUCOLLAGEN, LLC. 164
13.8 GELITA AG 165
13.9 NITTA GELATIN INC. 166
13.10 PB GELATIN 167
*Details on Overview, Recent Developments, Key relationships might not be captured in case of unlisted companies.
14 APPENDIX 168
14.1 DISCUSSION GUIDE 168
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 172
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 174
14.4 AVAILABLE CUSTOMIZATIONS 175
14.5 RELATED REPORTS 176
14.6 AUTHOR DETAILS 177   

 

LIST OF TABLES

2015-2022 (USD MILLION) 45
TABLE 2 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015-2022 (KILOGRAMS) 46
TABLE 3 BOVINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 47
TABLE 4 BOVINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 47
TABLE 5 PORCINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 48
TABLE 6 PORCINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 48
TABLE 7 MARINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 49
TABLE 8 MARINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 49
TABLE 9 OTHER COLLAGENS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 50
TABLE 10 OTHER COLLAGENS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 50
TABLE 11 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015-2022 (USD MILLION) 52
TABLE 12 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS) 53
TABLE 13 BOVINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 53
TABLE 14 BOVINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (TONS) 54
TABLE 15 PORCINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 54
TABLE 16 PORCINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (TONS) 55
TABLE 17 OTHER GELATINS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 55
TABLE 18 OTHER GELATINS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (TONS) 56
TABLE 19 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (USD MILLION) 58
TABLE 20 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (KILOGRAMS) 59
TABLE 21 COMMERCIALLY AVAILABLE COLLAGEN SCAFFOLDS FOR BONE REGENERATION 59
TABLE 22 ORTHOPEDIC APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION) 60
TABLE 23 ORTHOPEDIC APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS) 60
TABLE 24 WOUND CARE APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION) 61
TABLE 25 WOUND CARE APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS) 62
TABLE 26 CARDIOVASCULAR APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION) 62
TABLE 27 CARDIOVASCULAR APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS) 63
TABLE 28 OTHER APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2015-2022 (USD MILLION) 63
TABLE 29 OTHER APPLICATIONS: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2015-2022 (KILOGRAMS) 64
TABLE 30 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (USD MILLION) 66
TABLE 31 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (TONS) 67
TABLE 32 WOUND CARE APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION) 67
TABLE 33 WOUND CARE APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (TONS) 68
TABLE 34 ORTHOPEDIC APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2015-2022 (USD MILLION) 69
TABLE 35 ORTHOPEDIC APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2015-2022 (TONS) 69
TABLE 36 CARDIOVASCULAR AND THORACIC APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION) 70
TABLE 37 CARDIOVASCULAR AND THORACIC APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (TONS) 70
TABLE 38 OTHER APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2015-2022 (USD MILLION) 71
TABLE 39 OTHER APPLICATIONS: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2015-2022 (TONS) 71
TABLE 40 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 74
TABLE 41 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (KILOGRAMS) 74
TABLE 42 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2015–2022 (USD MILLION) 76
TABLE 43 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2015–2022 (KILOGRAMS) 76
TABLE 44 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY SOURCE, 2015–2022 (USD MILLION) 76
TABLE 45 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY SOURCE, 2015–2022 (KILOGRAMS) 77
TABLE 46 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (USD MILLION) 77
TABLE 47 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (KILOGRAMS) 78
TABLE 48 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 79
TABLE 49 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 79
TABLE 50 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 80
TABLE 51 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (KILOGRAMS) 80
TABLE 52 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 81
TABLE 53 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 82
TABLE 54 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 82
TABLE 55 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 83
TABLE 56 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 85
TABLE 57 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (KILOGRAMS) 85
TABLE 58 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 86
TABLE 59 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 86
TABLE 60 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 87
TABLE 61 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 87
TABLE 62 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 88
TABLE 63 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 89
TABLE 64 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 89
TABLE 65 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (KILOGRAMS) 90
TABLE 66 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 91
TABLE 67 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 91
TABLE 68 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 92
TABLE 69 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (KILOGRAMS) 92
TABLE 70 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 95
TABLE 71 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (KILOGRAMS) 95
TABLE 72 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (USD MILLION) 96
TABLE 73 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (KILOGRAMS) 96
TABLE 74 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (USD MILLION) 97
TABLE 75 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (KILOGRAMS) 97
TABLE 76 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 98
TABLE 77 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 98
TABLE 78 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 99
TABLE 79 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 99
TABLE 80 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 100
TABLE 81 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 100
TABLE 82 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 101
TABLE 83 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 101
TABLE 84 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 102
TABLE 85 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 102
TABLE 86 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 103
TABLE 87 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 103
TABLE 88 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 104
TABLE 89 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 104
TABLE 90 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 105
TABLE 91 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 105
TABLE 92 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 107
TABLE 93 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 107
TABLE 94 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 108
TABLE 95 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 108
TABLE 96 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 111
TABLE 97 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015–2022 (TONS) 111
TABLE 98 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 113
TABLE 99 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (TONS) 113
TABLE 100 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (USD MILLION) 114
TABLE 101 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (TONS) 114
TABLE 102 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (USD MILLION) 115
TABLE 103 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (TONS) 115
TABLE 104 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 116
TABLE 105 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 117
TABLE 106 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 117
TABLE 107 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 118
TABLE 108 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 119
TABLE 109 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 119
TABLE 110 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 120
TABLE 111 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 120
TABLE 112 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 122
TABLE 113 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (TONS) 122
TABLE 114 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 122
TABLE 115 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 123
TABLE 116 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 123
TABLE 117 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 124
TABLE 118 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 125
TABLE 119 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 125
TABLE 120 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 126
TABLE 121 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 126
TABLE 122 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 127
TABLE 123 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 127
TABLE 124 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 128
TABLE 125 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 128
TABLE 126 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 130
TABLE 127 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (TONS) 131
TABLE 128 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (USD MILLION) 131
TABLE 129 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (TONS) 132
TABLE 130 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 132
TABLE 131 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 133
TABLE 132 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 133
TABLE 133 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 134
TABLE 134 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 134
TABLE 135 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 135
TABLE 136 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 135
TABLE 137 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 136
TABLE 138 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 136
TABLE 139 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 137
TABLE 140 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 137
TABLE 141 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 138
TABLE 142 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 138
TABLE 143 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 139
TABLE 144 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 139
TABLE 145 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 140
TABLE 146 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 140
TABLE 147 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 141
TABLE 148 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 142
TABLE 149 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 143
TABLE 150 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 143
TABLE 151 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 144
TABLE 152 AGREEMENTS, COLLABORATIONS, AND CONTRACTS, 2014–2017 147
TABLE 153 ACQUISITIONS (2014–2017) 149
TABLE 154 APPROVALS, BY COMPANY (2014–2017) 150
TABLE 155 OTHER STRATEGIES (2014–2017) 151   

 

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE 19
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 22
FIGURE 4 KEY DATA FROM PRIMARY SOURCES 23
FIGURE 5 KEY INSIGHTS FROM INDUSTRY EXPERTS 24
FIGURE 6 COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE: MARKET SIZE ESTIMATION METHODOLOGY 25
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR COLLAGEN MARKET FOR REGENERATIVE MEDICINE 25
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR GELATIN MARKET FOR REGENERATIVE MEDICINE 26
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE 26
FIGURE 10 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH FOR COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE 27
FIGURE 11 RESEARCH DESIGN 27
FIGURE 12 DATA TRIANGULATION METHODOLOGY 28
FIGURE 13 GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE (2017) 30
FIGURE 14 GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE
(2017 VS. 2022) 31
FIGURE 15 GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION (2017 VS. 2022) 32
FIGURE 16 GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION
(2017 VS. 2022) 33
FIGURE 17 ASIA-PACIFIC TO RECORD HIGHEST GROWTH IN GLOBAL COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE DURING 2017-2022 34
FIGURE 18 INCREASING GOVERNMENT AND PRIVATE SUPPORT THE KEY GROWTH DRIVER OF COLLAGEN MARKET FOR REGENERATIVE MEDICINE 35
FIGURE 19 ASIA-PACIFIC GELATIN MARKET FOR REGENERATIVE MEDICINE TO RECORD HIGHEST GROWTH DURING 2017-2022 36
FIGURE 20 BOVINE COLLAGEN SEGMENT TO DOMINATE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, IN 2017 36
FIGURE 21 WOUND CARE APPLICATION SEGMENT TO CONTINUE DOMINATING GELATIN MARKET FOR REGENERATIVE MEDICINE IN 2022 37
FIGURE 22 ASIA-PACIFIC TO RECORD HIGHEST GROWTH DURING 2017-2022 37
FIGURE 23 ASIA-PACIFIC TO RECORD HIGHEST GROWTH DURING 2017-2022 38
FIGURE 24 DRIVERS, RESTRAINTS, AND OPPORTUNITIES 40
FIGURE 25 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE (USD MILLION) 45
FIGURE 26 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2017 VS. 2022 (USD MILLION) 52
FIGURE 27 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 58
FIGURE 28 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 66
FIGURE 29 NORTH AMERICA TO DOMINATE GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE IN 2017 73
FIGURE 30 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 75
FIGURE 31 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 84
FIGURE 32 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 94
FIGURE 33 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 106
FIGURE 34 NORTH AMERICA TO DOMINATE GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE IN 2017 110
FIGURE 35 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 112
FIGURE 36 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 121
FIGURE 37 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 130
FIGURE 38 REST OF THE WORLD (ROW): GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 142
FIGURE 39 KEY DEVELOPMENTS AMONG PROMINENT PLAYERS IN COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE (2014–2017) 145
FIGURE 40 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND CONTRACTS FORMED KEY GROWTH STRATEGY DURING 2014 TO 2017 146
FIGURE 41 AGREEMENTS, COLLABORATIONS, AND CONTRACTS, BY COMPANY (2014–2017) 147
FIGURE 42 ACQUISITIONS, BY COMPANY (2014-2017) 148
FIGURE 43 APPROVALS, BY COMPANY (2014–2017) 149
FIGURE 44 OTHER STRATEGIES, BY COMPANY (2014–2017) 150
FIGURE 45 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT 152
FIGURE 46 COLLAGEN SOLUTIONS PLC: COMPANY SNAPSHOT 157
FIGURE 47 ROYAL DSM: COMPANY SNAPSHOT 160
FIGURE 48 NITTA GELATIN INC.: COMPANY SNAPSHOT (2015) 166

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Collagen & Gelatin Market for Regenerative Medicine Worth 679.9 and 94.9 million USD Respectively, by 2022


August 8, 2017

The report "Collagen & Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis - Global Forecast to 2022", The global collagen market for regenerative medicine is projected to grow from USD 420.6 Million in 2017 to USD 679.9 Million by 2022, at a CAGR of 10.1% during the forecast period. The global gelatin market for regenerative medicine is projected to grow from USD 65.2 Million in 2017 to USD 94.9 Million by 2022, at a CAGR of 7.8% during the forecast period. The key factors propelling the growth of the global collagen and gelatin market for regenerative medicine include rising prevalence of chronic diseases, rapid growth in aging population, and growing government & private funding to support the development of regenerative medicine.

The bovine collagen segment accounted for the largest share of the market in 2017

By source, the global collagen market for regenerative medicine has been segmented into bovine collagen, porcine collagen, marine collagen, and other sources. In 2017, the bovine collagen segment is expected to command the largest share of the global collagen market for regenerative medicine. The large share of this segment is attributed to the lower cost and extensive availability of bovine collagen.

The orthopedic applications accounted for the largest share of the global collagen market for regenerative medicine in 2017

On the basis of application, the global collagen market for regenerative medicine has been segmented into orthopedic, wound care, cardiovascular, and other applications. In 2017, the orthopedic applications segment is expected to command the largest share of the global collagen market for regenerative medicine. The large share of this segment can primarily be attributed to the high prevalence of osteoporosis.

The orthopedic applications accounted for the largest share of the global gelatin market for regenerative medicine in 2017

On the basis of application, the global gelatin market for regenerative medicine has been segmented into wound care, orthopedic, cardiovascular & thoracic, and other applications. The wound care segment is expected to command the largest share of the global gelatin market for regenerative medicine in 2017. This segment is also projected to register the highest CAGR during the forecast period. Gelatin hydrogels provide a moist environment for healing while protecting the wound, with the additional advantage of being comfortable for patients due to their cooling effect and non-adhesiveness to wound tissue.

North America dominated the market in 2017

In 2017, North America is expected to account for the largest share of the collagen market for regenerative medicine. The high incidence of periodontitis, increasing prevalence of heart diseases and diabetes in the U.S., and growing number of research studies in Canada are the major factors supporting the growth of this market. The Asia-Pacific region is projected to register the highest growth rate during the forecast period.

The major players operating in the global collagen market for regenerative medicine include Integra LifeSciences Holding Corporation (U.S.), Collagen Matrix, Inc. (U.S.), Collagen Solutions plc (U.K.), Royal DSM (Netherlands), Vornia Biomaterials, Ltd. (Ireland), SYMATESE (France), and NuCollagen, LLC. (U.S.). The major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium).

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る